{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-0", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 0, "text": "Mobocertinib: MedlinePlus Drug Information\nwebsite belongs to an official government organization in the United States.\n(\nLock\nmeans you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n→\n→\nMobocertinib\nMobocertinib\npronounced as (moe boe\" ser' ti nib)\nWhy is this medication prescribed?\nHow should this medicine be used?\nOther uses for this medicine\nWhat special precautions should I follow?\nWhat special dietary instructions should I follow?\nWhat should I do if I forget a dose?\nWhat side effects can this medication cause?\nWhat should I know about storage and disposal of this medication?\nIn case of emergency/overdose\nWhat other information should I know?\nBrand names\nNotice:\nMobocertinib is no longer commercially available in the U.S. See the FDA website (\nhttps://www.accessdata.fda.gov/scripts/cder/daf/\n) for information on drugs that have been discontinued.\nIMPORTANT WARNING:\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-1", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 1, "text": "/\n) for information on drugs that have been discontinued.\nIMPORTANT WARNING:\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nMobocertinib may cause QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death). Tell your doctor if you or anyone in your family has or has ever had long QT syndrome (an inherited condition in which a person is more likely to have QT prolongation) or you have or have ever had low levels of potassium or magnesium in your blood, an irregular heartbeat, or heart failure."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-2", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 2, "text": "nherited condition in which a person is more likely to have QT prolongation) or you have or have ever had low levels of potassium or magnesium in your blood, an irregular heartbeat, or heart failure. Tell your doctor and pharmacist if you are taking any of the following medications: amiodarone (Nexterone, Pacerone); azithromycin (Zithromax); ciprofloxacin (Cipro); clarithromycin; disopyramide (Norpace); dofetilide (Tikosyn); dronedarone (Multaq); erythromycin (E.E.S., Eryc, Ery-tab, Erythrocin); fluconazole (Diflucan); certain medications for HIV such as atazanavir (Reyataz), indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); haloperidol (Haldol); ibutilide (Corvert); itraconazole (Sporanox, Tolsura); ketoconazole; levofloxacin; moxifloxacin; ondansetron (Zofran); procainamide; quinidine (in Nuedexta); sotalol (Betapace, Sorine, Sotylize); or voriconazole (Vfend). If you experience any of the following symptoms, call your doctor immediately: fast, pounding, or irregular heartbeat; dizziness; lightheadedness; or fainting.\nKeep all appointments with your doctor and the laboratory."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-3", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 3, "text": "ny of the following symptoms, call your doctor immediately: fast, pounding, or irregular heartbeat; dizziness; lightheadedness; or fainting.\nKeep all appointments with your doctor and the laboratory. Your doctor will order certain tests, such as blood tests and electrocardiograms (EKGs, tests that record the electrical activity of the heart) before and during your treatment to be sure that it is safe for you to take mobocertinib.\nTalk to your doctor about the risks of taking mobocertinib.\nWhy is this medication prescribed?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nMobocertinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that cannot be removed by surgery and has spread to other parts of the body either during or after treatment with platinum chemotherapy medications. Mobocertinib is in a class of medications called kinase inhibitors."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-4", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 4, "text": "moved by surgery and has spread to other parts of the body either during or after treatment with platinum chemotherapy medications. Mobocertinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors.\nHow should this medicine be used?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nMobocertinib comes as a capsule to take by mouth. It is usually taken once daily with or without food. The length of your treatment depends on how well this medication works for you, and the side effects that you experience. Take mobocertinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take mobocertinib exactly as directed."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-5", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 5, "text": "he same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take mobocertinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.\nSwallow the capsules whole; do not open, chew, crush, or dissolve them.\nIf you vomit after taking mobocertinib, do not take another dose. Continue your regular dosing schedule.\nYour doctor may decrease your dose, or interrupt or discontinue your treatment. This depends on how well the medication works for you and the side effects you experience. Talk to your doctor about how you are feeling during your treatment. Continue to take mobocertinib even if you feel well. Do not stop taking mobocertinib without talking to your doctor.\nAsk your pharmacist or doctor for a copy of the manufacturer's information for the patient.\nOther uses for this medicine\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-6", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 6, "text": "the manufacturer's information for the patient.\nOther uses for this medicine\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nThis medication may be prescribed for other uses; ask your doctor or pharmacist for more information.\nWhat special precautions should I follow?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nBefore taking mobocertinib,\ntell your doctor and pharmacist if you are allergic to mobocertinib, any other medications, or any of the ingredients in mobocertinib capsules. Ask your pharmacist for a list of the ingredients.\ntell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-7", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 7, "text": "ist of the ingredients.\ntell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril , enalapril (Epaned, Vasotec, in Vaseretic), fosinopril, lisinopril (Prinivil, Qbrelis, Zestril, in Zestoretic), moexipril, perindopril, (in Prestalia), quinapril (Accupril, in Accuretic, in Quinaretic), ramipril (Altace), and trandolapril; angiotensin receptor blockers (ARBs) such as azilsartan (Edarbi, in Edarbyclor), candesartan (Atacand, in Atacand HCT), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar, in Hyzaar), and valsartan (Diovan, in Diovan HCT, in Exforge, others); diuretics ('water pills'); efavirenz (Sustiva, in Atripla, in Symfi); hormonal contraceptives (birth control pills, patches, rings, implants, or injections); midazolam; rifampin (Rifadin, Rimactane); and sulfasalazine (Azulfidine)."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-8", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 8, "text": "renz (Sustiva, in Atripla, in Symfi); hormonal contraceptives (birth control pills, patches, rings, implants, or injections); midazolam; rifampin (Rifadin, Rimactane); and sulfasalazine (Azulfidine). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with mobocertinib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.\ntell your doctor if you have or have ever had asthma, emphysema, or other breathing problems (other than lung cancer); or kidney or liver disease.\ntell your doctor if you are pregnant, plan to become pregnant, or if you plan on fathering a child. If you are female, you will need to take a pregnancy test before you start treatment and use birth control to prevent pregnancy during your treatment and for 1 month after your final dose. Talk to your doctor about which methods you should use; hormonal contraceptives (birth control pills, patches, implants, rings, or injections) may not work well in women who are taking mobocertinib."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-9", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 9, "text": "Talk to your doctor about which methods you should use; hormonal contraceptives (birth control pills, patches, implants, rings, or injections) may not work well in women who are taking mobocertinib. If you are a male, you and your partner should use birth control during your treatment with mobocertinib and for 7 days after your final dose. If you or your partner become pregnant while taking mobocertinib, call your doctor immediately. Mobocertinib may harm the fetus.\ntell your doctor if you are breastfeeding. You should not breastfeed while you are taking mobocertinib and for 7 days after the final dose.\nyou should know that mobocertinib often causes diarrhea, which can be severe. Call your doctor if you have diarrhea while taking mobocertinib. Your doctor may tell you to drink plenty of liquids, make changes in your diet, and take medication to control the diarrhea and prevent dehydration (loss of too much water from your body)."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-10", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 10, "text": "ocertinib. Your doctor may tell you to drink plenty of liquids, make changes in your diet, and take medication to control the diarrhea and prevent dehydration (loss of too much water from your body). Call your doctor immediately if you experience any of the following symptoms of dehydration: extreme thirst, dry mouth and/or skin, decreased urination, sunken eyes, or fast heartbeat.\nWhat special dietary instructions should I follow?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nDo not eat grapefruit or drink grapefruit juice while taking this medication.\nWhat should I do if I forget a dose?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-11", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 11, "text": "uit juice while taking this medication.\nWhat should I do if I forget a dose?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nIf you miss a dose by less than 6 hours, take the missed dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose by more than 6 hours, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.\nWhat side effects can this medication cause?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nMobocertinib may cause side effects."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-12", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 12, "text": "DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nMobocertinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:\nnausea\nvomiting\nmouth sores\ndecreased appetite\nweight loss\nstomach pain\nheartburn\nrash\ndry skin or itching\nred, itchy, or irritated eyes\nblurry vision\nhair loss\nnail infection\ntiredness\nmuscle or bone pain\nfatigue\nrunny nose\nheadache\nSome side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section and call your doctor immediately or get emergency medical treatment:\ndiarrhea\ncough\nfever\nshortness of breath\nchest pain\nswelling of your ankles and feet\nMobocertinib may cause other side effects."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-13", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 13, "text": "on and call your doctor immediately or get emergency medical treatment:\ndiarrhea\ncough\nfever\nshortness of breath\nchest pain\nswelling of your ankles and feet\nMobocertinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.\nIf you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (\nhttps://www.fda.gov/Safety/MedWatch\n) or by phone (1-800-332-1088).\nWhat should I know about storage and disposal of this medication?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nKeep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).\nKeep all medication out of sight and reach of children as many containers are not child-resistant. Always lock safety caps."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-14", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 14, "text": "m temperature and away from excess heat and moisture (not in the bathroom).\nKeep all medication out of sight and reach of children as many containers are not child-resistant. Always lock safety caps. Place the medication in a safe location - one that is up and away and out of their sight and reach.\nhttps://www.upandaway.org\nDispose of unneeded medications in a way so that pets, children, and other people cannot take them. Do not flush this medication down the toilet. Use a medicine take-back program. Talk to your pharmacist about take-back programs in your community. Visit the FDA's Safe Disposal of Medicines website\nhttps://goo.gl/c4Rm4p\nfor more information.\nIn case of emergency/overdose\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nIn case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at\nhttps://www.poisonhelp.org/help\n."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-15", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 15, "text": "e consulted for more recently available information.\nIn case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at\nhttps://www.poisonhelp.org/help\n. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.\nWhat other information should I know?\nBecause this drug is no longer available in the U.S. market, the material in this section is no longer updated by AHFS DI. If this drug is used in countries other than the U.S., it is essential that the manufacturers' labeling be consulted for more recently available information.\nYour doctor will order a lab test before you begin your treatment to see whether your cancer can be treated with mobocertinib.\nDo not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.\nKeep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048-16", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a621048.txt", "chunk_index": 16, "text": "nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital. You should carry the list with you in case of emergencies.\nBrand names\nExkivity\n®\nLast Revised -\n10/15/2023"}
